Association of increased platelet-associated immunoglobulins with thrombocytopenia and the severity of disease in secondary dengue virus infections

Clinical and Experimental Immunology

Volumn 138, Issue 2, 2004, Pages 299-303

  Saito, M ^a   Oishi, K ^a   Inoue, S ^a   Dimaano, E M ^b   Alera, M T P ^b   Robles, A M P ^b   Estrella Jr , B D ^b   Kumatori, A ^a   Moji, K ^a   Alonzo, M T ^c   Buerano, C C ^c,d   Matias, R R ^c,d   Morita, K ^a   Natividad, F F ^c   Nagatake, T ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b San Lazaro Hospital   (Philippines)

^c ST LUKE S MEDICAL CENTER   (Philippines)

^d University of the Philippines Diliman   (Philippines)

Author keywords

Dengue haemorrhagic fever; PAIgG; PAIgM; Secondary infection; Thrombocytopenia

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ACUTE DISEASE; ADOLESCENT; ADULT; ANTIVIRAL ACTIVITY; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; CONVALESCENCE; DENGUE; DISEASE SEVERITY; HUMAN; HUMAN CELL; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SUPERINFECTION; THROMBOCYTE; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

ADOLESCENT; BLOOD PLATELETS; DENGUE; DENGUE HEMORRHAGIC FEVER; HEMATOCRIT; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PLATELET COUNT; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; THROMBOCYTOPENIA;

EID: 8144227340     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2004.02626.x     Document Type: Article

References (31)

1. Igarashi A. Impact of dengue virus infection and its control. FEMS Immunol Med M/C 1997; 18:291-300.
2. Guzman MG, Kouri G. Dengue: an update. Lancet Infect Dis 2002; 2:33-42.
3. Srichaikul T, Nimmannitya S. Haematology in dengue and dengue haemorrhagic fever. Bailliere's Clin Haematol 2000; 13:261-76.
4. Burke DS, Nisalak A, Jhonson DE, Scott RM. A prospective study of dengue infections in Bangkok. Am J Trop Med Hyg 1988; 38:172-80.
5. Halstead SB. Pathogenesis of dengue: challenges of molecular biology. Science 1988; 239:476-81.
6. Guzman MG, Kouri GP, Bravo J, Soler M, Vazquez S, Morier L. Dengue hemorrhagic fever in Cuba, 1981: a retrospective seroepidemiologic study. Am J Trop Med Hyg 1990; 42:179-84.
7. La Russa VF, Innis BL. Mechanism of dengue virus-induced bone marrow suppression. Bailliere's Clin Haematol 1995; 8:249-70.
8. Mitrakul C, Poshyachinda M, Futralul P, Sangkawibha N, Ahandrik S. Hemostatic and platelet kinetic studies in dengue hemorrhagic fever. Am J Trop Med Hyg 1977; 26:975-84.
9. Boonpucknavig S, Vuttiviroj O, Bunnag C, Bhamarapravati N, Nimmanitya S. Demonstration of dengue antibody complexes on the surface of platelets from patients with dengue hemorrhagic fever. Am J Trop Med Hyg 1979; 28:881-4.
10. McMillian R. Chronic idiopathic thrombocytopenic purpura. N Engl J Med 1981; 304:1135-47.
11. Cines DB, Blanchette VS, Chir B. Immune thrombocytopenic purpura. N Engl J Med 2002; 346:995-1008.
12. Muller-Eckhardt C, Kayser W, Mersch-Baumert K et al. The clinical significance of platelet-associated IgG: a study on 298 patients with various disorders. Br J Haematol 1980; 46:123-31.
13. Rand ML, Wright JF. Virus-associated idiopathic thrombocytopenic purpura. Transfus Sci 1998; 19:253-9.
14. Kitamura K, Ohta H, Ihara T et al. Idiopathic thrombocytopenic purpura after human herpesvirus 6 infection. Lancet 1994; 344:830.
15. Toyoshige M, Takahashi H. Increase of platelet-associated IgG (PAIgG) and hemophagocytosis of neutrophils and platelets in parvovirus B19 infection. Int J Hematol 1998; 67:205-6.
16. Oishi K, Inoue S, Cinco MTDD et al. Correlation between increased platelet-associated IgG and thrombocytopenia in secondary dengue virus infections. J Med Virol 2003; 71:259-64.
17. Wang S, He R, Patarapotikul J, Innis BL, Anderson R. Antibody-enhanced binding of dengue-2 virus to human platelet. Virology 1995; 213:254-7.
18. Innis BL, Nisalak A, Nimmannitya S et al. An enzyme-linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis co-circulate. Am J Trop Med Hyg 1989; 40:418-27.
19. Bundo K, Igarashi A. Antibody-captured ELISA for detection of immunoglobulin M antibodies in sera from Japanese encephalitis and dengue hemorrhagic fever patients. J Virol Meth 1985; 11:15-22.
20. Morita K, Tanaka M, Igarashi A. Rapid identification of dengue virus serotypes by using polymerase chain reaction. J Clin Microbiol 1991; 29:2107-10.
21. World Health Organization (WHO). Dengue haemorrhagic fever: diagnosis, treatment, prevention and control, 2nd edn. Geneva: WHO, 1997.
22. Libraty DH, Endy TP, Houng HH et at. Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infection. J Infect Dis 2002; 185:1213-21.
23. Clarke DH, Casals J. Techniques for hemagglutination and hemagglutination-inhibition with arthropod-borne viruses. Am J Trop Med Hyg 1958; 7:561-73.
24. Helmerhorst FM, van Oss CJ, Bruynes ECE, von Engelfriet CP, dem Borne AEGKr. Elution of granulocyte and platelet antibodies. Vox Sang 1982; 43:196-204.
25. Bokisch VA, Top FH Jr, Russell PK, Dixon FJ, Muller-Eberhard HJ. The potential pathogenic role of complement in dengue hemorrhagic shock syndrome. N Engl J Med 1973; 289:996-1000.
26. Green S, Vaughn DW, Kalayanarooj S et al. Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity. 1999; 179:755-62.
27. Murgue B, Cassar O, Deparis X. Plasma concentrations of sVCAM-1 and severity of dengue infections. J Med Virol 2001; 65:97-104.
28. Libraty DH, Young PR, Pickering D et al. High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with development of dengue hemorrhagic fever. J Infect Dis 2002; 186:1165-8.
29. Krishnamurti C, Peat RA, Cutting MA, Rothwell SW. Platelet adhesion to dengue-2 virus-infected endothelial cells. Am J Trop Med Hyg 2002; 66:435-41.
30. Krishnamurti C, Kalayanarooj S, Cutting MA et al. Mechanisms of hemorrhage in dengue without circulatory collapse. Am J Trop Med Hyg 2001; 65:840-7.
31. Avirutnan P, Malasit P, Seliger B, Bhakdi S, Husmann M. Dengue virus infection of human endothelial cells leads to chemokine production, complement activation, and apoptosis. J Immunol 1998; 161:6338-46.